Development of zero-link polymers of hemoglobin, which do not extravasate and do not induce pressure increases upon infusion
- PMID: 17364467
- PMCID: PMC2464266
- DOI: 10.1080/10731190600974277
Development of zero-link polymers of hemoglobin, which do not extravasate and do not induce pressure increases upon infusion
Abstract
Intramolecular crosslink of hemoglobin tetramers solved the problem of urine elimination and short intravascular retention time of cell free hemoglobin infusion. It also produced a family of crosslinked hemoglobins with P50 between 18 and 30 mmHg. However, it did not solve the problem of MAP increases in infused animals. It was proven that extravasation of hemoglobin into interstitial fluid was responsible for MAP increases. Extravasation and the MAP increase was avoided using a hemoglobin polymer with average size near 25 MDa. In spite of a very high oxygen affinity, this polymer delivered oxygen to tissues, producing either vasodilation or vasoconstriction according to oxygen needs. It was also proven that cell free hemoglobins are more efficient than red cells in delivering oxygen to tissues.
Figures





Similar articles
-
Vascular response to infusions of a nonextravasating hemoglobin polymer.J Appl Physiol (1985). 2002 Oct;93(4):1479-86. doi: 10.1152/japplphysiol.00191.2002. J Appl Physiol (1985). 2002. PMID: 12235050
-
Sustained endothelial dependent dilation in pial arterioles after crosslinked hemoglobin transfusion.Artif Cells Blood Substit Immobil Biotechnol. 1997 Jan-Mar;25(1-2):115-20. doi: 10.3109/10731199709118903. Artif Cells Blood Substit Immobil Biotechnol. 1997. PMID: 9083632
-
Submicron biodegradable polymer membrane hemoglobin nanocapsules as potential blood substitutes: a preliminary report.Artif Cells Blood Substit Immobil Biotechnol. 1994;22(3):889-93. doi: 10.3109/10731199409117926. Artif Cells Blood Substit Immobil Biotechnol. 1994. PMID: 7994414
-
S-nitrosylated polyethylene glycol-conjugated hemoglobin derivative as a candidate material for oxygen therapeutics.Adv Exp Med Biol. 2003;519:207-16. doi: 10.1007/0-306-47932-X_13. Adv Exp Med Biol. 2003. PMID: 12675217 Review. No abstract available.
-
Hemoglobin-based oxygen carriers: first, second or third generation? Human or bovine? Where are we now?Crit Care Clin. 2009 Apr;25(2):279-301, Table of Contents. doi: 10.1016/j.ccc.2009.01.003. Crit Care Clin. 2009. PMID: 19341909 Review.
Cited by
-
Polymerized Human Hemoglobin-Based Oxygen Carrier Preserves Lung Allograft Function During Normothermic Ex Vivo Lung Perfusion.ASAIO J. 2024 May 1;70(5):442-450. doi: 10.1097/MAT.0000000000002118. Epub 2024 Jan 24. ASAIO J. 2024. PMID: 38266069 Free PMC article.
-
Nanobiotechnological modification of hemoglobin and enzymes from this laboratory.Biochim Biophys Acta. 2008 Oct;1784(10):1435-40. doi: 10.1016/j.bbapap.2008.05.006. Epub 2008 Jun 17. Biochim Biophys Acta. 2008. PMID: 18565337 Free PMC article.
-
Blood substitutes: evolution from noncarrying to oxygen- and gas-carrying fluids.ASAIO J. 2013 Jul-Aug;59(4):337-54. doi: 10.1097/MAT.0b013e318291fbaa. ASAIO J. 2013. PMID: 23820271 Free PMC article. Review.
-
Pilot scale production and characterization of next generation high molecular weight and tense quaternary state polymerized human hemoglobin.Biotechnol Bioeng. 2022 Dec;119(12):3447-3461. doi: 10.1002/bit.28233. Epub 2022 Oct 3. Biotechnol Bioeng. 2022. PMID: 36120842 Free PMC article.
-
Molecular Design Properties of OxyVita Hemoglobin, a New Generation Therapeutic Oxygen Carrier: A Review.J Funct Biomater. 2011 Dec 16;2(4):414-24. doi: 10.3390/jfb2040414. J Funct Biomater. 2011. PMID: 24956452 Free PMC article.
References
-
- Bucci E, Razynska A, Kwansa H, Matheson-Urbaitis B, O’Hearne M, Ulatowski JA, Koehler RC. Production and characteristics of an infusible oxygen-carrying fluid based on hemoglobin intramolecularly cross-linked with sebacic acid. J Lab Clin Med. 1996;128:146–153. - PubMed
-
- Urbaitis BK, Razynska A, Corteza Q, Fronticelli C, Bucci E. Intravascular retention and renal handling of purified natural and intramolecularly crosslinked hemoglobins. J Lab Clin Med. 1991;117:115–121. - PubMed
-
- Ulatowski JA, Nishikawa T, Matheson-Urbaitis B, Bucci E, Traystman RJ, Koehler RC. Regional blood flow alterations after bovine fumaryl beta beta-crosslinked hemoglobin transfusion and nitric oxide synthase inhibition. Crit Care Med. 1996;24:558–565. - PubMed
-
- Matheson B, Razynska A, Kwansa HE, Bucci E. Appearance of dissociable and crosslinked hemoglobins in renal hilar lymph. J Lab Clin Inv. 2000;135:459–464. - PubMed
-
- Asano Y, Koehler RC, Ulatowski JA, Traystman RJ, Bucci E. Effect of cross-linked hemoglobin transfusion on endothelial-dependent dilation in cat pial arterioles. Am J Physiol Heart Circ Physiol. 1998;275:1313–21. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials